Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Substitution of lysine for isoleucine at the center of the nonpolar face of the antimicrobial peptide, piscidin-1, leads to an increase in the rapidity of bactericidal activity and a reduction in toxicity.
Taheri B, Mohammadi M, Momenzadeh N, Farshadzadeh Z, Roozbehani M, Dehghani P, Hajian S, Darvishi S, Shamseddin J. Taheri B, et al. Among authors: momenzadeh n. Infect Drug Resist. 2019 Jun 14;12:1629-1647. doi: 10.2147/IDR.S195872. eCollection 2019. Infect Drug Resist. 2019. PMID: 31354312 Free PMC article.
Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them.
Sani MZ, Bargahi A, Momenzadeh N, Dehghani P, Moghadam MV, Maleki SJ, Nabipour I, Shirkani A, Akhtari J, Hesamizadeh K, Heidari S, Omrani F, Akbarzadeh S, Mohammadi M. Sani MZ, et al. Among authors: momenzadeh n. Appl Microbiol Biotechnol. 2021 Jan;105(1):77-91. doi: 10.1007/s00253-020-11012-0. Epub 2020 Nov 20. Appl Microbiol Biotechnol. 2021. PMID: 33215260
Corrigendum to "Photothermic therapy with cuttlefish ink-based nanoparticles in combination with anti-OX40 mAb achieve remission of triple-negative breast cancer" [Int. Immunopharmacol. 115 (2023) 109622].
Momenzadeh N, Hajian S, Shabankare A, Ghavimi R, Kabiri-Samani S, Kabiri H, Hesami-Zadeh K, Shabankareh ANT, Nazaraghay R, Nabipour I, Mohammadi M. Momenzadeh N, et al. Int Immunopharmacol. 2023 Nov;124(Pt B):111035. doi: 10.1016/j.intimp.2023.111035. Epub 2023 Oct 18. Int Immunopharmacol. 2023. PMID: 37858486 No abstract available.